CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Efficacy of dose-reduced lenalidomide in patients with refractory or recurrent multiple myeloma
Authors
German Refractory Myeloma Study Group
Axel Glasmacher
+3 more
Marcus Gorschlüter
Ingo G. H. Schmidt-Wolf
Katharina Schwamborn
Publication date
1 January 2011
Publisher
German Medical Science GMS Publishing House
Doi
Cite
View
on
PubMed
Abstract
Purpose: Introduction of lenalidomide has expanded the therapeutic options for refractory and recurrent multiple myeloma (MM) patients. However, the application of the approved doses may be difficult in some patients due to adverse effects
Similar works
Full text
Open in the Core reader
Download PDF
Available Versions
German Medical Science
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:oai-gms.dimdi.de:GA000149
Last time updated on 09/07/2019
Directory of Open Access Journals
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:doaj.org/article:4ab2788eb...
Last time updated on 18/12/2014
